FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells
0
조회
0
다운로드
1
인용
0
참고문헌
초록
Extracellular signal-regulated kinase 3 (ERK3) is an atypical member of the mitogen-activated protein kinase (MAPK) family, members of which play essential roles in diverse cellular processes during carcinogenesis, including cell proliferation, differentiation, migration, and invasion. Unlike other MAPKs, ERK3 is an unstable protein with a short half-life. Although deubiquitination of ERK3 has been suggested to regulate the activity, its ubiquitination has not been described in the literature. Here, we report that FBXW7 (F-box and WD repeat domain-containing 7) acts as a ubiquitination E3 ligase for ERK3. Mammalian two-hybrid assay and immunoprecipitation results demonstrated that ERK3 is a novel binding partner of FBXW7. Furthermore, complex formation between ERK3 and the S-phase kinase-associated protein 1 (SKP1)-cullin 1-F-box protein (SCF) E3 ligase resulted in the destabilization of ERK3 via a ubiquitination-mediated proteasomal degradation pathway, and FBXW7 depletion restored ERK3 protein levels by inhibiting this ubiquitination. The interaction between ERK3 and FBXW7 was driven by binding between the C34D of ERK3, especially at Thr417 and Thr421, and the WD40 domain of FBXW7. A double mutant of ERK3 (Thr417 and Thr421 to alanine) abrogated FBXW7-mediated ubiquitination. Importantly, ERK3 knockdown inhibited the proliferation of lung cancer cells by regulating the G1/S-phase transition of the cell cycle. These results show that FBXW7-mediated ERK3 destabilization suppresses lung cancer cell proliferation in vitro.
Abstract
Extracellular signal-regulated kinase 3 (ERK3) is an atypical member of the mitogen-activated protein kinase (MAPK) family, members of which play essential roles in diverse cellular processes during carcinogenesis, including cell proliferation, differentiation, migration, and invasion. Unlike other MAPKs, ERK3 is an unstable protein with a short half-life. Although deubiquitination of ERK3 has been suggested to regulate the activity, its ubiquitination has not been described in the literature. Here, we report that FBXW7 (F-box and WD repeat domain-containing 7) acts as a ubiquitination E3 ligase for ERK3. Mammalian two-hybrid assay and immunoprecipitation results demonstrated that ERK3 is a novel binding partner of FBXW7. Furthermore, complex formation between ERK3 and the S-phase kinase-associated protein 1 (SKP1)-cullin 1-F-box protein (SCF) E3 ligase resulted in the destabilization of ERK3 via a ubiquitination-mediated proteasomal degradation pathway, and FBXW7 depletion restored ERK3 protein levels by inhibiting this ubiquitination. The interaction between ERK3 and FBXW7 was driven by binding between the C34D of ERK3, especially at Thr417 and Thr421, and the WD40 domain of FBXW7. A double mutant of ERK3 (Thr417 and Thr421 to alanine) abrogated FBXW7-mediated ubiquitination. Importantly, ERK3 knockdown inhibited the proliferation of lung cancer cells by regulating the G1/S-phase transition of the cell cycle. These results show that FBXW7-mediated ERK3 destabilization suppresses lung cancer cell proliferation in vitro.
참고문헌 (42)
- Coulombe, P., "Atypical mitogen-activated protein kinases : structure, regulation and functions", Biochim. Biophys. Acta, 1773, pp.1376~1387 (2007)
- Payne, D. M., "Identification of the regulatory phosphorylation sites in pp42", mitogen-activated protein kinase(MAP kinase), 1991, pp.10, 885~892
- English, J., "New insights into the control of MAP kinase pathways", Exp. Cell Res, 253, pp.255~270 (1999)
- Schaeffer, H. J., "Mitogen-activated protein kinases : specific messages from ubiquitous messengers", Mol. Cell. Biol, 19, pp.2435~2444 (1999)
- Coulombe, P., "Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation", Mol. Cell. Biol, 23, pp.4542~4558 (2003)
- Coulombe, P., "N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome", Mol. Cell. Biol, 24, pp.6140~6150 (2004)
- Julien, C., "Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression", J. Biol. Chem, 278, pp.42615~42624 (2003)
- Evtimova, V., "Identification of breast cancer metastasis-associated genes by chip technology", Anticancer Res, 21, pp.3799~3806 (2001)
- Liang, B., "Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer", World J. Gastroenterol, 11, pp.623~628 (2005)
- Nambiar, S., "Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays", Arch. Dermatol, 141, pp.165~173 (2005)
- Bhattacharjee, A., "Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses", Proc. Natl Acad. Sci. USA, 98, pp.13790~13795 (2001)
- Long, W., "ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion", J. Clin. Investig, 122, pp.1869~1880 (2012)
- Alsaran, H., "L290P", V mutations increase ERK3’s cytoplasmic localization and migration, Sci. Rep, pp.2017, 7[DOI]
- Elkhadragy, L., "Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness", J. Biol. Chem, 293, pp.16193~16205 (2018)
- Almeqdadi, M., "Gut organoids : mini-tissues in culture to study intestinal physiology and disease", Am. J. Physiol. Cell. Physiol, 317, pp.C405~C419 (2019)
- Bogucka, K., "ERK3", MAPK6 controls IL-8 production and chemotaxis, 2020, pp.9, e52511~
- El-Merahbi, R., "The adrenergic-induced ERK3 pathway drives lipolysis and suppresses energy dissipation", Genes Dev, 34, pp.495~510 (2020)
- Anhe, G. F., "ERK3 associates with MAP2 and is involved in glucose-induced insulin secretion", Mol. Cell. Endocrinol, 251, pp.33~41 (2006)
- Kassouf, T., "Impact of conventional and atypical MAPKs on the development of metabolic diseases", Biomolecules, 10, pp.1256~ (2020)
- Bai, C., "SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box", Cell, 86, pp.263~274 (1996)
- Welcker, M., "A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size", Curr. Biol, 14, pp.1852~1857 (2004)
- Orlicky, S., "Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase", Cell, 112, pp.243~256 (2003)
- Nash, P., "Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication", Nature, 414, pp.514~521 (2001)
- Rajagopalan, H., "Inactivation of hCDC4 can cause chromosomal instability", Nature, 428, pp.77~81 (2004)
- Lee, C. J., "FBXW7-mediated stability regulation of signal transducer and activator of transcription 2 in melanoma formation", Proc. Natl Acad. Sci. USA, 117, pp.584~594 (2020)
- Deleris, P., "Activation loop phosphorylation of the atypical MAP kinases ERK3and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5", J. Cell. Physiol, 217, pp.778~788 (2008)
- Aredia, F., "Analysis of ERK3 intracellular localization : dynamic distribution during mitosis and apoptosis", Eur. J. Histochem, 59, pp.2571~ (2015)
- Hansen, C. A., "A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3", Cell Cycle, 7, pp.325~334 (2008)
- Klinger, S., "Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality", Proc. Natl Acad. Sci. USA, 106, pp.16710~16715 (2009)
- Ronkina, N., "Germ line deletion reveals a nonessential role of atypical mitogen-activated protein kinase 6", extracellular signal-regulated kinase 3, 2019, pp.39, e00516~e00518
- Soulez, M., "Reevaluation of the role of extracellular signal-regulated kinase 3in perinatal survival and postnatal growth using new genetically engineered mouse models", Mol. Cell. Biol, 39, pp.e00527~18 (2019)
- Schumacher, S., "Scaffolding by ERK3 regulates MK5 in development", EMBO J, 23, pp.4770~4779 (2004)
- Ding, L., "Somatic mutations affect key pathways in lung adenocarcinoma", Nature, 455, pp.1069~1075 (2008)
- Durinck, S., "Temporal dissection of tumorigenesis in primary cancers", Cancer Discov, 1, pp.137~143 (2011)
- Kostenko, S., "Tumour promoting and suppressing roles of the atypical MAP kinase signalling pathway ERK3", 4-MK5, 2012, pp.7, 9~
- Akhoondi, S., "FBXW7", hCDC4 is a general tumor suppressor in human cancer, 2007, pp.67, 9006~9012
- Chen, M., "The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness", J. Cell. Physiol, 234, pp.13220~13232 (2019)
- Boonstra, J., "Regulation of enzyme activity in vivo is determined by its cellular localization", Adv. Enzym. Regul, 44, pp.61~73 (2004)
- Kant, S., "Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5", J. Biol. Chem, 281, pp.35511~35519 (2006)
- Aberg, E., "Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4", MAPK4, 2006, pp.281, 35499~35510
- Rodriguez, J., "Substrate-trapped interactors of PHD3 and FIH cluster in distinct signaling pathways", Cell Rep, 14, pp.2745~2760 (2016)
- Mathien, S., "Deubiquitinating enzyme USP20 regulates extracellular signal-regulated kinase 3 stability and biological activity", Mol. Cell. Biol, 37, pp.e00432~16 (2017)